The contribution of

Wilms tumor YTHDF2 m6A polymorphism susceptibility

Journal

Journal of Cancer
ISSN: 1837-9664
Titre abrégé: J Cancer
Pays: Australia
ID NLM: 101535920

Informations de publication

Date de publication:
2021
Historique:
received: 29 04 2021
accepted: 09 08 2021
entrez: 20 9 2021
pubmed: 21 9 2021
medline: 21 9 2021
Statut: epublish

Résumé

YTHDF2 is responsible for maintaining the dynamic N

Identifiants

DOI: 10.7150/jca.62154 PMID: 34539889 PMC: PMC8425210
pubmed: 34539889
doi: 10.7150/jca.62154
pii: jcav12p6165
pmc: PMC8425210
doi:

Types de publication

Journal Article

Langues

eng

Pagination

6165-6169

Informations de copyright

© The author(s).

Déclaration de conflit d'intérêts

Competing Interests: The authors have declared that no competing interest exists.

Références

J Cell Mol Med. 2016 Aug;20(8):1481-90
pubmed: 27019310
Melanoma Res. 2019 Aug;29(4):382-389
pubmed: 30762711
Biochem Biophys Res Commun. 2020 Jan 8;521(2):499-506
pubmed: 31677788
EBioMedicine. 2018 Apr;30:113-119
pubmed: 29544698
Cancer Res. 2019 Apr 1;79(7):1285-1292
pubmed: 30894375
Gene. 2020 Sep 5;754:144839
pubmed: 32504654
J Pediatr Surg. 2019 Mar;54(3):390-397
pubmed: 30270120
Carcinogenesis. 2020 Mar 13;41(1):8-17
pubmed: 31579913
Cell Res. 2017 Mar;27(3):315-328
pubmed: 28106072
Zhonghua Er Ke Za Zhi. 2013 Apr;51(4):288-94
pubmed: 23927803
Biochemistry. 2019 Feb 5;58(5):363-378
pubmed: 30557013
Nat Genet. 2012 Apr 29;44(6):681-4
pubmed: 22544364
Oncogene. 2020 Jun;39(23):4507-4518
pubmed: 32366907
Hum Mol Genet. 2020 Oct 20;29(R2):R138-R149
pubmed: 32412586
J Gene Med. 2020 Nov;22(11):e3255
pubmed: 32716082
Oncogene. 2019 May;38(19):3667-3680
pubmed: 30659266
Aging (Albany NY). 2019 Mar 12;11(5):1551-1563
pubmed: 30860980
Nat Rev Nephrol. 2019 Apr;15(4):240-251
pubmed: 30705419
J Cell Mol Med. 2020 Apr;24(7):4092-4104
pubmed: 32126149
Nat Commun. 2016 Aug 25;7:12626
pubmed: 27558897
J Natl Cancer Inst. 1997 Aug 6;89(15):1148-52
pubmed: 9262253
Genes Chromosomes Cancer. 2008 Jun;47(6):461-70
pubmed: 18311776
J Pediatr Hematol Oncol. 2009 Apr;31(4):256-8
pubmed: 19346876
Onco Targets Ther. 2019 Nov 05;12:9143-9152
pubmed: 31806999
Cell. 1990 Jun 29;61(7):1257-69
pubmed: 2163761
Biochem Biophys Res Commun. 2019 May 7;512(3):479-485
pubmed: 30905413
J Cell Mol Med. 2019 Oct;23(10):7105-7110
pubmed: 31338973
Nature. 1991 Oct 3;353(6343):431-4
pubmed: 1654525
EBioMedicine. 2016 Jul;9:120-129
pubmed: 27333041
Pediatr Dev Pathol. 2000 Nov-Dec;3(6):561-7
pubmed: 11000334
Mol Cancer. 2019 Nov 18;18(1):163
pubmed: 31735169
Mol Ther Nucleic Acids. 2020 Mar 6;19:804-813
pubmed: 31958696
Biosci Rep. 2019 Jan 22;39(1):
pubmed: 30610160
Mol Cancer. 2019 May 29;18(1):103
pubmed: 31142332
Cell. 1975 Apr;4(4):379-86
pubmed: 164293
Cell Prolif. 2020 Mar;53(3):e12768
pubmed: 31967701
Med Pediatr Oncol. 1993;21(3):172-81
pubmed: 7680412
Children (Basel). 2018 Oct 26;5(11):
pubmed: 30373137
Genes Dev. 2015 Mar 1;29(5):467-82
pubmed: 25737276
Nat Rev Cancer. 2005 Sep;5(9):699-712
pubmed: 16110318
Nat Cell Biol. 2018 Mar;20(3):285-295
pubmed: 29476152
J Occup Med. 1984 Jun;26(6):427-35
pubmed: 6330324
J Clin Lab Anal. 2020 Jun;34(6):e23251
pubmed: 32091154
Cell Stem Cell. 2019 Jul 3;25(1):137-148.e6
pubmed: 31031138
Mol Ther Nucleic Acids. 2020 Aug 14;22:17-26
pubmed: 32891980
J Pediatr Surg. 2003 Feb;38(2):259-61
pubmed: 12596119
Am J Epidemiol. 1995 Feb 1;141(3):210-7
pubmed: 7840094
Mol Ther. 2020 Feb 5;28(2):599-612
pubmed: 31839484
Carcinogenesis. 2020 Jul 10;41(5):541-550
pubmed: 31504235
Nature. 2014 Jan 2;505(7481):117-20
pubmed: 24284625

Auteurs

Zhiyuan Wang (Z)

Department of Pathology, The First Affiliated Hospital of Kunming Medical University, Kunming 650031, Yunnan, China.

Zhenjian Zhuo (Z)

Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623, Guangdong, China.

Linyan Li (L)

Department of Clinical Laboratory, Yunnan Key Laboratory of Laboratory Medicine, the First Affiliated Hospital of Kunming Medical University, Kunming 650032, Yunnan, China.

Rui-Xi Hua (RX)

Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623, Guangdong, China.

Li Li (L)

Kunming Key Laboratory of Children Infection and Immunity, Yunnan Key Laboratory of Children's Major Disease Research, Yunnan Institute of Pediatrics Research, Yunnan Medical Center for Pediatric Diseases, Kunming Children's Hospital, Kunming 650228, Yunnan, China.

Jiao Zhang (J)

Department of Pediatric Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China.

Jiwen Cheng (J)

Department of Pediatric Surgery, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, Shaanxi, China.

Haixia Zhou (H)

Department of Hematology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, Zhejiang, China.

Suhong Li (S)

Department of Pathology, Children Hospital and Women Health Center of Shanxi, Taiyuan 030013, Shannxi, China.

Jing He (J)

Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623, Guangdong, China.

Shan Yan (S)

Yunnan Key Laboratory of Stem Cell and Regenerative Medicine, Biomedical Engineering Research Center, Kunming Medical University, Kunming 650500, Yunnan, China.

Classifications MeSH